Raymond James & Associates’s Aterian ATER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,480
Closed -$524K 4094
2021
Q1
$524K Buy
+1,480
New +$570K ﹤0.01% 2979

Other funds holding ATER

Raymond James & Associates's ATER Position: Q2 2021 in Review

Raymond James & Associates sold out of Aterian (ATER) in Q2 2021, closing a stake of 1,480 shares — an estimated $524K sold.

Raymond James & Associates first reported a position in ATER in Q1 2021 and held it in 1 quarter. The position peaked at $524K in Q1 2021. 82 funds tracked by Wall St. Rank hold ATER as of Q2 2021.

  • Raymond James & Associates reported no remaining Aterian position as of Q2 2021 after selling out during the quarter.
  • Raymond James & Associates sold 1,480 Aterian shares in Q2 2021, an estimated $524K.
  • Raymond James & Associates first reported a position in Aterian in Q1 2021 and held it in 1 quarter.
  • Raymond James & Associates's Aterian position peaked at $524K in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Aterian as of Q2 2021.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.